Medical Condition News

RSS

New therapeutic approach shows potential for treating cancer

Case Western Reserve researchers have identified a two-pronged therapeutic approach that shows great potential for weakening and then defeating cancer cells.

31 Dec 2014

Tikcro enters into research and license agreement with Yeda

Tikcro Technologies Ltd. today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel.

30 Dec 2014

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.

30 Dec 2014

Overeaters Anonymous offers support for people struggling with food addiction

It's that time of year again – another New Year, another New Year's resolution. For many people, dealing with compulsive eating issues and the pressure to shed unwanted weight, the New Year can often be a stress trigger that leads to guilt, depression, embarrassment and even more eating and unwanted pounds.

30 Dec 2014

Study: Sugar molecule promotes spontaneous cancers in mice

While people who eat a lot of red meat are known to be at higher risk for certain cancers, other carnivores are not, prompting researchers at the University of California, San Diego School of Medicine to investigate the possible tumor-forming role of a sugar called Neu5Gc, which is naturally found in most mammals but not in humans.

30 Dec 2014

STS, ESTS collaborate to help improve lung cancer care

A unique collaboration between The Society of Thoracic Surgeons and the European Society of Thoracic Surgery will help improve the quality of patient care by linking outcomes data on chest procedures, beginning with lung cancer surgery, according to an article in the January 2015 issue of The Annals of Thoracic Surgery.

30 Dec 2014

G-treeBNT files IND with MFDS for Phase IIB/III clinical trial of RGN-259 for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.

29 Dec 2014

Newron, Zambon announce re-submission of safinamide NDA to FDA

Newron Pharmaceuticals S.p.A., a research and development company focused on novel CNS and pain therapies, and its commercial and development partner Zambon S.p.A., an international pharmaceutical company, announced today that the NDA for safinamide has been re-submitted to the US FDA.

29 Dec 2014

Top notch endodontic care for patients with dental anxiety

It's no secret that vast majority of Americans don't look forward to a visit to the dentist. According to the American Association of Endodontists, a striking 80% of US adults experience dental fear or anxiety. On some levels, fear of the dentist is understandable because a checkup or a procedure involves poking and prodding around the mouth of a patient with an intimidating looking set of tools.

29 Dec 2014

Negative health effects of severe obesity

The negative health effects of severe obesity are very well known and have been thoroughly documented, yet obesity levels in the United States continue to remain stubbornly high. Many of these repercussions are life threatening and include heart attack, stroke, and a greatly increased chance of developing cancer.

27 Dec 2014

Three common health problems tied to oral health

Many people think that going to the dentist is all about getting a bright and shining smile. While this is an important aspect of dentistry, an experienced dentist like Farzad Feiz, DDS, of Calabasas Dental Group and California Dental Care can also help patients with their overall health.

27 Dec 2014

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 entitled "Method of Treating Binge Eating Disorder."

26 Dec 2014

United Therapeutics submits pre-market approval application for use of Remodulin with implantable drug infusion system

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.

25 Dec 2014

RMG’s Simi Valley Diabetes Clinic offers free diabetes care for members

Regal Medical Group (RMG) today announced its Simi Valley Diabetes Clinic, offering free diabetes care for members, has helped more than 200 patients receive comprehensive, individualized, successful treatment.

25 Dec 2014

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.

25 Dec 2014

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Novastem, a leader in regenerative medicine, announces the treatment of its first patient in its study for ischemic stroke at Clinica Santa Clarita.

25 Dec 2014

Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial

Kinex Pharmaceuticals announced today that the first patient has been dosed with KX2-361 at Roswell Park Cancer Institute.

25 Dec 2014

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

25 Dec 2014

FDA approves Namzaric drug for treatment of moderate to severe Alzheimer's disease

Actavis plc and Adamas Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Namzaric, a fixed-dose combination (FDC) of memantine hydrochloride extended-release, a NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor.

25 Dec 2014

Scrapie pathogens can convert human prion protein to a pathological state

INRA scientists have shown for the first time that the pathogens responsible for scrapie in small ruminants (prions) have the potential to convert the human prion protein from a healthy state to a pathological state. In mice models reproducing the human species barrier, this prion induces a disease similar to Creutzfeldt-Jakob disease.

24 Dec 2014

Medical Condition News

New therapeutic approach shows potential for treating cancer

Tikcro enters into research and license agreement with Yeda

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Overeaters Anonymous offers support for people struggling with food addiction

Study: Sugar molecule promotes spontaneous cancers in mice

STS, ESTS collaborate to help improve lung cancer care

G-treeBNT files IND with MFDS for Phase IIB/III clinical trial of RGN-259 for dry eye syndrome

Newron, Zambon announce re-submission of safinamide NDA to FDA

Top notch endodontic care for patients with dental anxiety

Negative health effects of severe obesity

Three common health problems tied to oral health

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

United Therapeutics submits pre-market approval application for use of Remodulin with implantable drug infusion system

RMG’s Simi Valley Diabetes Clinic offers free diabetes care for members

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial

Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension

FDA approves Namzaric drug for treatment of moderate to severe Alzheimer's disease

Scrapie pathogens can convert human prion protein to a pathological state

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News